- Biopharma pay report: Top-paid CSOs, CMOs of 2025Biopharma’s top scientists and doctors don’t make nearly as much as CEOs, but some still took in eight-figure pay packages in 2025. As part of our series on industry compensation, Endpoints News…Endpoints · 1mo ago↗ source
- Kardigan plans $320M IPO for heart drugs as Nasdaq listings gain steamParabilis Medicines' record-breaking IPO will be a tough act to follow, but a drug developer with three late-stage cardio medicines is up for the challenge. It's led by a CEO who sold ...Endpoints · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and moreMore employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medications